ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC36435-2mg |
|
1441674-54-9 |
Ledipasvir acetone
|
0 | C52H60F2N8O7 | |
GC36435-10mM (in 1mL DMSO) |
|
1441674-54-9 |
Ledipasvir acetone
|
0 | C52H60F2N8O7 | |
GC36433-50mg |
|
2310134-98-4 |
LDN193189 Tetrahydrochloride
|
0 | C25H26Cl4N6 | |
GC36433-5mg |
|
2310134-98-4 |
LDN193189 Tetrahydrochloride
|
0 | C25H26Cl4N6 | |
GC36433-2mg |
|
2310134-98-4 |
LDN193189 Tetrahydrochloride
|
0 | C25H26Cl4N6 | |
GC36433-10 mM ( 1 mL in Water) |
|
2310134-98-4 |
LDN193189 Tetrahydrochloride
|
0 | C25H26Cl4N6 | |
GC36431-1g |
|
52-89-1 |
L-Cysteine hydrochloride
|
0 | C3H8ClNO2S | |
GC36430-100mg |
|
944795-06-6 |
Lck inhibitor 2
|
0 | C18H17N5O2 | |
GC36430-50mg |
|
944795-06-6 |
Lck inhibitor 2
|
0 | C18H17N5O2 | |
GC36430-10mg |
|
944795-06-6 |
Lck inhibitor 2
|
0 | C18H17N5O2 | |
GC36430-5mg |
|
944795-06-6 |
Lck inhibitor 2
|
0 | C18H17N5O2 | |
GC36430-10mM (in 1mL DMSO) |
|
944795-06-6 |
Lck inhibitor 2
|
0 | C18H17N5O2 | |
GC36428-100mg |
|
613677-28-4 |
Lasmiditan hydrochloride
|
0 | C19H19ClF3N3O2 | |
GC36428-50mg |
|
613677-28-4 |
Lasmiditan hydrochloride
|
0 | C19H19ClF3N3O2 | |
GC36428-10mg |
|
613677-28-4 |
Lasmiditan hydrochloride
|
0 | C19H19ClF3N3O2 | |
GC36428-5mg |
|
613677-28-4 |
Lasmiditan hydrochloride
|
0 | C19H19ClF3N3O2 | |
GC36428-10mM (in 1mL DMSO) |
|
613677-28-4 |
Lasmiditan hydrochloride
|
0 | C19H19ClF3N3O2 | |
GC36427-10mM (in 1mL DMSO) |
|
25999-20-6 |
Lasalocid sodium
|
0 | C34H53NaO8 | |
GC36427-5mg |
|
25999-20-6 |
Lasalocid sodium
|
0 | C34H53NaO8 | |
GC36427-50mg |
|
25999-20-6 |
Lasalocid sodium
|
0 | C34H53NaO8 | |